About
Biography
Dr. Tamara Tilburgs obtained her Ph.D. degree in Reproductive Immunology at Leiden University Medical Center, Leiden, Netherlands in the lab of Dr. Frans Claas, where she studied decidual T cell responses in healthy human pregnancies. She conducted a postdoctoral fellowship and held an Instructor position in Dr. Jack Strominger’s laboratory at the Department of Stem Cell and Regenerative Biology at Harvard University, where she focused on the molecular mechanisms of immune tolerance by HLA-G+ extravillous trophoblasts.
Currently, Dr. Tilburgs’ is an Assistant Professor at Cincinnati Children’s Hospital Medical Center, where she investigates how maternal immune cells at the maternal-fetal interface establish tolerance to fetal antigens while at the same time maintaining immunity to viral and bacterial infections. She has published over 25 peer-reviewed papers in the area of reproductive immunology with a more specific scientific production in the field of immune regulatory mechanisms by HLA-G+ extravillous trophoblasts and decidual regulatory T cells as well as decidual NK cell and decidual effector T cell responses to placental and viral antigens.
PhD: Leiden University Medical Center, Leiden, Netherlands, 2004-2008.
Post Doctoral Fellowship: Harvard University, Cambridge, MA, 2009-2013.
Instructor: Harvard University, Cambridge, MA, 2014-2019.
Interests
Pregnancy complications; contribution of placental inflammatory responses to development of spontaneous preterm birth and preeclampsia
Interests
Mechanisms of maternal-fetal immune tolerance and placental immunity in human pregnancy
Research Areas
Immunobiology, Inflammation and Tolerance
Publications
Decidual NK Cells Transfer Granulysin to Selectively Kill Bacteria in Trophoblasts. Cell. 2020; 182:1125-1139.e18.
The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal Interface. Frontiers in Immunology. 2019; 10.
Three Types of Functional Regulatory T Cells Control T Cell Responses at the Human Maternal-Fetal Interface. Cell Reports. 2019; 27:2537-2547.e5.
HLA-G: At the Interface of Maternal-Fetal Tolerance. Trends in Immunology. 2017; 38:272-286.
Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections. Journal of Reproductive Immunology. 2017; 119:85-90.
Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection. Proceedings of the National Academy of Sciences of the United States of America. 2016; 113:15072-15077.
A distant trophoblast-specific enhancer controls HLA-G expression at the maternal-fetal interface. Proceedings of the National Academy of Sciences of the United States of America. 2016; 113:5364-5369.
The HLA-G cycle provides for both NK tolerance and immunity at the maternal-fetal interface. Proceedings of the National Academy of Sciences of the United States of America. 2015; 112:13312-13317.
CD8+ effector T cells at the fetal-maternal interface, balancing fetal tolerance and antiviral immunity. American Journal of Reproductive Immunology and Microbiology. 2013; 69:395-407.
Two unique human decidual macrophage populations. Journal of Immunology. 2011; 186:2633-2642.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2022 Cincinnati Children's Hospital Medical Center. All rights reserved.
